Could ETQ's share price be soon to benefit from their developments with the new UVGI Nightingale Mobile Air Filtration Product.

New UVGI air filtration product

In November 2002, the ETQ announced its new Nightingale UVGI air filtration product, to be produced by a new joint-venture company, UVGI Systems Limited, owned 55% by the Group and 45% by Suvair Limited. This rapid response mobile air filtration unit is capable of killing the MRSA super bug and other airborne pathogens.

The UVGI unit has widespread application where there is need to keep
air free of dangerous live bacteria, viruses, and fungal spores, including
hospitals, schools, cruise liners, aircraft, food processing, and military
applications.

The UVGI unit uses a high intensity Ultra Violet Germicidal Irradiation ('UVGI')
filter, which has been designed to control harmful and dangerous airborne
pathogens, such as Anthrax, Tuberculosis, and Staphylococcus aureus, the
causative agent in MRSA. The filtration system is combined with use of high
intensity Ultra Violet light, which inactivates micro organisms by disrupting
their DNA structure.

Tests of a prototype at the Defence Science Technology Laboratory ('Dstl') at
Porton Down, the centre for excellence for the Ministry of Defence, showed that
the UVGI unit captured and/or destroyed more than 99.9% of Bacillus subtilis
spores, a simulant for Anthrax bacteria.

Since November, second generation units have been developed, which will go on
applications testing at an NHS Trust Hospital in December 2003, following
building completion of its new haematology unit. It is also anticipated the
UVGI unit will shortly go on laboratory testing in the United States with
contractors nominated by the Department of Homeland Security.

Concern seems to be hotting up on the T.V. news that the MRSA super bug is still killing and disabling people visiting or as patients in NH Trust hospitals. It would be surprising if NH Trust hospital do not notice and Buy this product before they get to many expensive law suits for compensation claims.

Definitely a stock that could soon be heading north. Worth buying in but DYOR

L.

RELATED NEWS LINKS

Sky News Sun 28th Sept 03 - NEW ANTIBIOTICS WARNING
BBC World News Thurs 4th December 03 - Hospital infections: Case studies
BBC World News Fri 5th Dec 03 - 'Superbug' crackdown is launched
BBC World News Monday 22nd Dec 03 - Superbugs lurk in intensive care
Sky News Sun 14th Dec 03 - SUPERBUG CARRIED BY PETS
BBC World News Thurs 26th Feb 04 - Superbug deaths increase 15-fold
BBC World News Mon 22nd March 04 - MRSA superbug hits more children
BBC World News Fri 2nd April 04 - Superbug outbreak in cardiac ward
BBC World News Thurs 8th April 04 - NHS faces superbug legal claims
BBC World News Sun 6th June 04 - Government 'complacent' over MRSA
BBC World News Fri 18th June 04 - Superbug deaths 'set to double'
BBC World News Thurs 1st July 04 - Holland's tough line combats MRSA
BBC World News Thurs 1st July 04 - Overcrowded hospitals breed MRSA
ITV.com Fri 9th July 04 - Mother's MRSA nightmare
ITV.com Fri 9th July 04 - 'MRSA superbug has done this to me'
ITV.com Fri 9th July 04 - Precautions you can take against MRSA
Sky News Sun 11th July 04 - WAR DECLARED ON MRSA
BBC UK News Mon 12th July 04 - Drive to fight hospital superbugs

Legins looks like the recovery may be here at last ! I can remember when this beauty was 30p+

We have had constant selling so would expect a fairly strong rise if this buying spree continues.

Legins just been catching up.Take a look at this extract from the last figures released.I think I will add further tomorrow;

RNS Number:0121N
Energy Technique PLC
01 July 2003




Energy Technique Plc

Preliminary Announcement 2003

Chairman's Statement

Overview

In my first Chairman's Statement since my appointment in January 2003, I am
pleased to report the year ended 31 March 2003 has been a successful period for
the group:

- Profit before tax of #0.263 million compared with last year's loss of
#0.635 million.

- Balance sheet gearing has been further reduced to 78% from 118% at the
previous year-end.

- Diffusion Refrigeration and Distribution was formed as a distributor of
branded Panasonic and LG Electronics packaged air conditioning systems,
expanding the Group's market opportunity from #50 million to #500 million.

- The innovative new Nightingale UVGI air filtration product is nearing
commercial launch and has just won the coveted "Air Movement Product of the
year" at the HVAC industry's H & V News Awards 2003.

Group financial performance

Sales of #11.7 million remained at the same level as last year, but operating
profit improved by 37% to #0.369 million.

The Board is very pleased with this result, because the reported operating
profit is stated after charging to profits #0.417 million on research and
development, including in particular the new Nightingale air filtration product,
and #0.258 million start-up operating losses on Diffusion Refrigeration and
Distribution.

Profit before tax is #0.263 million, compared with last year's loss of #0.635
million, which included a loss on the disposal of Benson Heating. Profit before
tax on continuing activities improved by 18%.

Group cash flow

The Group generated a strong cash inflow from operating activities of #0.487
million, resulting in a further reduction in debt to #0.947 million at 31 March
2003, representing a gearing level of 78%. Interest paid was covered 3.5 times
by operating profit.

Working capital continued to be tightly controlled and has remained
substantially unchanged, notwithstanding a planned stock build of #0.285 million
to service the new Panasonic and LG Electronics distribution business.

Capital expenditure on plant, infrastructure, and computer systems amounted to
#0.2 million. This was the first year of a continuing capital expenditure
programme, which has started to redress the many years of under-investment
caused when the Group funded loss-making activities now disposed of.

Dividends

The Board does not recommend payment of a dividend.


Operations

ET Environmental experienced historically high levels of demand for its fan coil
and commercial heating products in the first nine months of the year, but the
air conditioning market took a sudden downturn in January, following the
deferral of certain property developments. This resulted in much lower sales in
the final quarter of the year, and regrettably in May 2003, 25 redundancies were
announced to adjust the cost base down to ongoing expected sales levels.

The formation of Diffusion Refrigeration and Distribution represents the first
steps in broadening the Group's product range with complementary packaged air
conditioning systems. The newly introduced Lifebreath air filtration and
Airtrade acoustics products build on this strategy. This new subsidiary
incurred start-up operating losses of #0.258 million in its first eight months
of trading.


New UVGI air filtration product

In November 2002, the Company was pleased to announce its exciting new
Nightingale UVGI air filtration product, to be produced by a new joint-venture
company, UVGI Systems Limited, owned 55% by the Group and 45% by Suvair Limited.
This rapid response mobile air filtration unit is capable of killing the MRSA
super bug and other airborne pathogens.

The Nightingale UVGI unit has widespread application where there is need to keep
air free of dangerous live bacteria, viruses, and fungal spores, including
hospitals, schools, cruise liners, aircraft, food processing, and military
applications.

The UVGI unit uses a high intensity Ultra Violet Germicidal Irradiation ("UVGI")
filter, which has been designed to control harmful and dangerous airborne
pathogens, such as Anthrax, Tuberculosis, and Staphylococcus aureus, the
causative agent in MRSA. The filtration system is combined with use of high
intensity Ultra Violet light, which inactivates micro organisms by disrupting
their DNA structure.

Tests of a prototype at the Defence Science Technology Laboratory ("Dstl") at
Porton Down, the centre for excellence for the Ministry of Defence, showed that
the UVGI unit captured and/or destroyed more than 99.9% of Bacillus subtilis
spores, a simulant for Anthrax bacteria.

Since November, second generation units have been developed, which will go on
applications testing at an NHS Trust Hospital in December 2003, following
building completion of its new haematology unit. It is also anticipated the
UVGI unit will shortly go on laboratory testing in the United States with
contractors nominated by the Department of Homeland Security.

Directors

The Board is saddened to report the ill health of Steve McNeice, the Group
Finance Director and Company Secretary. The Board wishes Steve a speedy
recovery.

Geoffrey Dart stepped down as Chairman and from the Board on 28 January 2003.
Paul Barham resigned from the Board on 18 March 2003. I would like to thank
them both for their contribution to the restructuring of Energy Technique plc
over the past two years.

Gerard Thompson was appointed to the Board on 26 March 2003 as a non-executive
director. He brings significant experience to the Board in finance and
technology development.

Robert Unsworth was re-appointed to the Board on 1 July 2003 as an executive
director, responsible for finance and company secretarial matters during Steve
McNeice's absence.


Management and employees

On behalf of the Board, I would like to thank all employees for their continued
hard work, dedication and commitment during the year, and particularly during
the current testing market conditions.


Current trading and prospects

The Group incurred a loss in April and May due to redundancy costs incurred in
May and to very low sales levels, particularly in April. The low sales were
attributed to significantly reduced market demand facing the air conditioning
sector. However, sales in May recovered and this has continued into June. The
current order book, enquiry levels and outlook are now much more encouraging
than in the early part of 2003 and the Board remains optimistic about the
Group's prospects.

Since November the Board has explored many potential opportunities for marketing
and further developing the exciting new Nightingale UVGI air filtration unit,
and a number of these are turning into potential business opportunities. The
UVGI product has the potential for improving the Group's financial performance,
and the Board is exploring opportunities for raising the capital necessary to
fully exploit the potential of the UVGI product. The Board expects to make
further announcements updating shareholders on this and other UVGI developments
in due course.



Graham R Mackenzie
Chairman

Last few avaialble at 9.5p ;-)

Good buying today. Maybe a buy order being filled at this level which is holding the price back !!

We should have figures this week or very soon. Any news on the Nightingale unit will certainly have a marked impact on the share price !

On news I have seen ETQ rise by over a 100% !!

DYOR but don't be left out of this oversold beauty ;-)

LOL !

3 on the bid 1 on the offer. Next move very soon ;-)

LOL !

anyone knows the result date? thanks.

Was the 19/11 last year.

Good day.One of the only BLUE stocks on my monitor.Some good buying at the end and with 3 vs 1 on L2 I would expect to see a quick move up tomorrow.

Another good day. Don;t expect to hold that 10.5p offer for much longer !

I have recently done some legwork and managed to speak at length to the senior management who work for the company on the UVGI division. Here is the latest info I’ve gleaned from ETQ.

Energy Technique already have their new stand alone Nightingale UGVI air conditioning & filtering units in production and available to ship customer orders with delivery in just two weeks.

Most existing air conditioning units in office blocks and public buildings have the air inlet and outlet exhaust grills at ceiling level so do not efficiently exchange the air at floor to desk zone (the lower half of a room). It is at this zone that a very large percentage of the population congregates to work, study, wait or socialise and breath in contagious viruses and germs in the atmosphere. One of the biggest causes of the loss in productivity and profits for industry & commerce is sick leave for the common cold, flu, or other strains of virulent chest infections.

The circle of cross infection with bronchial viruses doesn’t care where it starts but infections most often start with your children who are more prone to respiratory & chest infections and pick them up in the classroom, they take the infection home and give it to their parents who in turn, take it into the office and infect their colleagues who in turn, take it home and infect their children. And so it goes on, ad-infinitum.

ETQ says their Free-Standing Nightingale UGVI Unit, is the ultimate weapon for industry and commerce to significantly reduce the absenteeism in companies’ workforces from these illnesses. The unit has been specifically designed to remove any air that can become contagious with air-born cold & flu viruses from the workplace & frequented public indoor spaces where people congregate. The UGVI units extract air from the floor zone and returns clean decontaminated air to desk & standing height zones where cross infection amongst a workforce would otherwise most likely take place.

With two different sized free-standing “Plug and Play” models now in production and available for delivery, it is now at no better time of the annual season for industry & commerce to buy these units for their workplaces, its late autumn, winter and early spring when they are in most need to prevent cross infection off their staff. National and Local Government Departments and Authorities ought to be the first buyers of the UGVI filtered units for schools, hospitals and other public buildings. ETQ are putting their sales and marketing efforts into winning the orders that eventually will come through as it’s the waiting game for committees and budgets to be approved.

However, ETQ’s Nightingale UVGI division are placing their priorities in their marketing efforts to sell the USP’s of ‘Plug & Play’ UVGI units to Industry and Commerce which they see will have immediate benefits to health & safety in workplaces. In the short term this is the market where they see their first orders will shortly be announced. The units should help UK Industry and Commerce to reduce employee sick leave and save ?Millions p.a. from losses in productivity.

In the medium term, ETQ believe that once the success of the use of the Nightingale UVGI units by Industry and Commerce in the workplace is proven that it significantly reduces the number of productivity hours lost through staff illness and absenteeism from these illnesses then, National & Local Governments would soon follow and buy the units for schools & colleges to protect school children & working families and break the circle of being cross infected.

In the long term, ETQ expect that the UVGI filters will be used in all public bus, coach and rail carriages, passenger ships & aircraft and perhaps eventually could almost eradicate cross infection of air-born viruses and germs. This cross-infection is something that is currently common place in society.

In my view the Nightingale will be a huge sucess for ETQ

http://www.uvgi.co.uk

What a Bullish chart



Good work Leggins.Can you please copy that onto ADVFN ?

Wow!

If that doesnt sound positive I don't know what does.....maybe a little optomistic on the world domination of air filtering..or not? If you don't mind i'll copy and paste it over on ample with credit where it is definately due..well done, thanks, we all knew we were holding on for something and once we see those order announcements then the rise will really start.

GN

See investors are still like Lemmings.Why did the price hold so well today ? A bargain at 11p.

late night Post by Legins on BB of ECK ( in error)


As perhaps you may know, ETQ's management want to get the Nightingale out in the market and being used as quickly as possible. Hence the reason they focused on the two stand-alone portable models first.

The cost of upgrading an existing air conditioning system in large buildings e.g. hospitals etc., would mean an extremely long lead-in time for the budgets for these types of contracts to be approved. This is because it is not just a simple matter of adding the filters to the air conditioning ductwork system but also to lower the position of the air extraction inlet and sanitised air outlet grills from ceilings to extracting air from floor level and deliver sanitised air at desk / standing zone of a room. Therefore, it would be sometime before sales for UVGI filters in existing air-conditioned systems for public, commercial & industrial buildings would show to build-up. New buildings in the future may well be designed to incorporate the Nightingale UVGI filters in new air conditioning systems but this will not happen overnight.

In the mean time, the stand-alone portable Nightingale UVGI filters are an immediately effective air sanitation unit that can work alongside air conditioning systems or on their own. These units give ETQ & UVGI a much faster route into the market and show its products effectiveness. The unit which will be on trial with NHS sometime next month will mean that relative quickly they will not just be accredited by Porton Down 'Dstl' but also by the U.K. public health authorities.

UVGI believe that the first companies to buy & make use of the filters is the Food Processing and Co's in industry, Insurance Co's in commerce & Passenger Cruise Lines Co's in Travel/Leisure industry.

I would have thought that it is near to the time UL labs in USA will have completed tests and accredited with approvals for entering that market. Certainly I think the City has some knowledge and confidence in this coming to fruition and news of this could be any time but are waiting for this to come out before the share price will begin to head north.

OK,

The next thing to find out is

What is the price of their product & what rival products are available or available soon & at what price?

Product Info

http://www.energytechniqueplc.co.uk/admin/upload/files/pdf/brochure3.pdf

ETQ has been mentioned in the Lancet...if it gets into the national press ETQ will fly.